U. von Hinüber

Comparison of the clinical efficacy and safety of subcutaneous versus oral administration of methotrexate in patients with active rheumatoid arthritis: Results of a six‐month, multicenter, randomized, double‐blind, controlled, phase IV trial

Jürgen Braun, Philipp Kastner, P. Flaxenberg et al. · Arthritis & Rheumatism · 2007 · 340 citations

Evolution of cost structures in rheumatoid arthritis over the past decade

Dörte Huscher, Thomas Mittendorf, U. von Hinüber et al. · Annals of the Rheumatic Diseases · 2014 · 113 citations · Full text

Ankylosing spondylitis causes high burden to patients and the healthcare system: results from a German claims database analysis

Klaus Krüger, U. von Hinüber, Florian Meier et al. · Rheumatology International · 2018 · 50 citations

Rheumatology, Healthcare System, Spondyloarthritis +10

ROUTINE—a prospective, multicentre, non-interventional, observational study to evaluate the safety and effectiveness of intravenous tocilizumab for the treatment of active rheumatoid arthritis in daily practice in Germany

Christof Iking‐Konert, U. von Hinüber, Constanze Richter et al. · Lara D. Veeken · 2015 · 44 citations · Full text

Sensitivity and Specificity of Autoantibodies Against <scp>CD</scp>74 in Nonradiographic Axial Spondyloarthritis

E. Riechers, N.T. Baerlecken, Xenofon Baraliakos et al. · Arthritis & Rheumatology · 2018 · 37 citations